November 2020 Lion John Mason, District Governor
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Annual Review 2007 Table of Contents
ANNUAL REVIEW 2007 TABLE OF CONTENTS BREAKING THE VICIOUS CIRCLE 4 TOMORROW’S BURDEN, TODAY’S BATTLE 6 Whereas type 1 and 2 diabetes are chronic PLANTING SEEDS FOR LONG TERM CHANGE 8 conditions, gestational diabetes mellitus (GDM) A HOLISTIC APPROACH – A NATIONAL NCD PROGRAMME 10 usually disappears after childbirth. However MAKING A DIFFERENCE IN TANZANIA 12 GDM can have serious consequences for the A CATALYST FOR CHANGE 14 health of the mother and child, both in the short SAVING FEET, SAVING FUTURES 16 and long term. GLOBAL DIABETES WALK 2007 18 The elevated blood glucose levels can affect the child PICTURE GALLERY 20 in the womb by increasing its weight abnormally, PROJECT ACTIVITIES 2007 21 or causing birth defects such as malformations in PREVENTING BLINDNESS IN RURAL INDIA 26 fingers and toes and can affect the heart and brain. SCREENING FOR DIABETES IN INDIA 28 In the state of Tamil Nadu COST EFFECTIVE PREVENTION OF DIABETES 30 in India, 10% of all 1.5 million annual pregnancies SUSTAINING HOPE FOR FUTURE GENERATIONS 32 end as miscarriages. The stillbirth rate is 14 per PRIMARY PREVENTION IN INDIAN SCHOOLS 34 1000 live births, covering all causes. It is estimated FIGHTING OBESITY AND ITS COMPLICATIONS IN CHINA 36 that 15% of the total number of caesarean sections may DIABETES SUMMIT AFRICA, KENYA 2007 38 be due to GDM. HIGH NOTES FOR A SERIOUS CAUSE 40 GDM is one of the focus areas of the ANNUAL ACCOUNTS 2007 42 World Diabetes Foundation. BREAKING THE VICIOUS CIRCLE Chronic diseases and poverty are interconnected in a vicious circle; as in almost all countries, the poorest people are the ones most at risk of developing chronic diseases and dying prematurely from the severe complications, or suffering long term from the associated morbidity. -
I'm Douglas Schwan, Member of the Juvenile Diabetes Foundation
I’m Douglas Schwan, member of the Juvenile Diabetes Foundation Board of Directors and a member of Insulin 4 All. I’m submitting written and oral testimony in support of S.B 1 & H.B. 5175. AN ACT CONCERNING DIABETES AND HIGH DEDUCTIBLE HEALTH PLANS. The bills are inadequate and lack mechanisms related to the publicly stated intentions of the bills. The bills are not strong enough and do not protect the very people the bills are intended to serve… the poor, working poor, and middle class. The current bills will only effect a small subset of the population they’re intended to serve. It’s estimated only 26% of Connecticut’s intended population, those that desperately need affordable insulin legislation, will actually get relief from the bills in their current, limited form. Why is the burden of lowering insulin costs for diabetics only being put onto insurance companies and distributors when the problem is with the manufacturers who set the original prices to begin with? This is completely backwards. I am tremendously grateful for insulin manufactures like Eli Lilly, Novo Nordisk and Sanofi. In short, we need them and can’t live without them. I truly appreciate you, and thank you, for all you have done to save the lives of so many of us in this room and across the globe. Yet I am profoundly uncomfortable, infuriated really, with the irony that we are here today, talking about saving diabetics’ lives because they can’t afford insulin. I’ve been there. If you really want to make insulin accessible and affordable you have to go to the source of the problem: • Pharmaceutical companies’ continuous evergreening of drug patents that guarantee a manipulated corporate welfare marketplace in favor of pharmaceutical companies on the backs of the Connecticut taxpayer. -
Department of Physiology Tirunelveli Medical College Tirunelveli – 627 011
A CROSS SECTIONAL STUDY TO CORRELATE THE DURATION OF DIABETES, GLYCEMIC CONTROL, AUTONOMIC NEUROPATHY AND DERMATOLOGICAL MANIFESTATIONS IN TYPE 2 DIABETES MELLITUS Dissertation submitted to THE TAMILNADU DR. M.G.R. MEDICAL UNIVERSITY, CHENNAI – 600 032 In partial fulfillment of the requirement for the degree of Doctor of Medicine in Physiology (Branch V) M.D. (PHYSIOLOGY) APRIL – 2017 DEPARTMENT OF PHYSIOLOGY TIRUNELVELI MEDICAL COLLEGE TIRUNELVELI – 627 011. CERTIFICATE This is to certify that the dissertation entitled, “A CROSS SECTIONAL STUDY TO CORRELATE THE DURATION OF DIABETES, GLYCEMIC CONTROL, AUTONOMIC NEUROPATHY AND DERMATOLOGICAL MANIFESTATIONS IN TYPE 2 DIABETES MELLITUS” by Dr. SUJATHA ANDREW, postgraduate in PHYSIOLOGY (2014-2017), is a bonafide research work carried out under our direct supervision and guidance and is submitted to The Tamilnadu Dr.M.G.R. Medical University, Chennai, for M.D., Degree Examination in Physiology (Branch V), to be held in April 2017. Dr. Ratna Manjushree Jayaraman M.D.,D.C.H., Dr.K. Sithy Athiya Munavarah, M.D., Associate Professor and Head , Dean, Department of Physiology, Tirunelveli Medical College, Tirunelveli Medical College, Tirunelveli – 11. Tirunelveli - 11. ENDORSEMENT BY THE GUIDE This is to certify that the dissertation entitled, “A CROSS SECTIONAL STUDY TO CORRELATE THE DURATION OF DIABETES, GLYCEMIC CONTROL, AUTONOMIC NEUROPATHY AND DERMATOLOGICAL MANIFESTATIONS IN TYPE 2 DIABETES MELLITUS’’ is a bonafide research work carried out by Dr. SUJATHA ANDREW in the Department of Physiology, Tirunelveli Medical College & Hospital, Tirunelveli – 11 under my direct guidance and supervision in partial fulfillment of the requirement for the award of the degree of M.D., in PHYSIOLOGY (Branch – V) in April 2017. -
TYPE 1 DIABETES a Very Special Issue 47
E U ISS GLOBAL PERSPECTIVES ON DIABETES Volume 56 – D ecember 2011 SPECIAL TYPE 1 DIABETES A very special issue 47 6 32 DiabetesVoice 43 CONTENTS DIABETES VIEWS 4 International Diabetes Federation Promoting diabetes care, prevention and a cure worldwide THE GLOBAL IMPACT Diabetes Voice is published quarterly and is freely available Estimating the worldwide burden of type 1 diabetes 6 Leonor Guariguata online at www.diabetesvoice.org. Hope springs for young people with type 1 diabetes 9 The production of this Special Issue has been made possible Graham Ogle and Larry Deeb thanks to the support of Sanofi Diabetes. The 3-C Study – strong partnerships to improve care This publication is also available in French, Spanish for people with type 1 diabetes in China 13 and Chinese. Linong Ji and Helen McGuire Editor-in-Chief: Stephanie A Amiel, UK MANAGEMENT, CARE AND PREVENTION Managing Editor: Olivier Jacqmain, [email protected] The key to managing diabetes without tears – the treatment and Editor: Tim Nolan, [email protected] Advisory group: Pablo Aschner (Colombia), teaching programme for flexible insulin therapy in Germany 16 Ruth Colagiuri (Australia), Patricia Fokumlah (Cameroon), Ulrich Alfons Müller Attila József (Hungary), Viswanathan Mohan (India). Taking the benefits of DAFNE to the UK and beyond 19 Layout and printing: Luc Vandensteene, Ex Nihilo, Belgium, Stephanie A Amiel, Julia Lawton, Simon Heller www.exnihilo.be Positive results in Australia – OzDAFNE takes up the challenge 22 All correspondence and advertising enquiries should be Dianne Harvey addressed to the Managing Editor: Never say never – implementing DAFNE in Kuwait 24 International Diabetes Federation, Chaussée de La Hulpe 166, Ebaa Alozairi 1170 Brussels, Belgium Phone: +32-2-5431626 – Fax: +32-2-5385114 – [email protected] Great results for DAFNE Singapore – next stop, South-East Asia 27 Su-Yen Goh and Daphne Gardner Making progress with immune therapies for type 1 diabetes 29 © International Diabetes Federation, 2010 – All rights reserved. -
Papers Coll 00334 Papers Contain Letters Written by Elizabeth Hughes
MS HUGHES (Elizabeth) Papers Coll 00334 Papers contain letters written by Elizabeth Hughes (1907-1981) to her mother, Antoinette (Mrs. Charles E.) Hughes, describing her activities and giving information about her health and diabetic condition. Letters dating from August to November 1922 describe Elizabeth’s experiences in Toronto where she was treated with insulin by F.G. Banting. Collection includes one letter written by Elizabeth's nurse, Blanche Burgess, enclosing a letter from Dr. F.M. Allen. 1921-1923. 53 letters. Papers also include 22 photographs of Elizabeth Hughes and her family, dating from 1907 to 1951, and a commemorative medal struck by the Eli Lilly Company in 1995. Total extent: 3 boxes (53 letters, 22 photos, 1 medal) The letters were donated in 1996 to the Fisher Library by Elizabeth Hughes’ husband, William T. Gossett, and their children: W. Thomas Gossett, Jr., Antoinette Carter (Gossett) Denning, and Elizabeth Evans (Gossett) Karaman. The original photographs were donated in 1996 by Theodore Hughes Waddell, a nephew of Elizabeth Hughes. Photographs o fElizabeth Hughes have also been copied from originals in the Supreme Court of the United States and in the Library of Congress, as indicated on the following listing. No reproduction of these copy photographs can be made without permission from the institution where the originals are held. January 1998 K.Martyn Ms.Coll HUGHES (ELIZABETH) PAPERS 334 • BIOGRAPHICAL NOTE Elizabeth Hughes (1907-1981) was the daughter ofAntoinette and Charles E. Hughes. Her father was U.S. Secretary ofState (1921-1925) and later Chief Justice ofthe United States (1930-1941). Elizabeth contracted severe diabetes in 1919 at age 11. -
Insulet Announces Sponsorship of International Diabetes Federation's World Diabetes Day Campaign
November 3, 2008 Insulet Announces Sponsorship of International Diabetes Federation's World Diabetes Day Campaign BEDFORD, Mass., Nov. 3 /PRNewswire-FirstCall/ -- Insulet Corporation, (Nasdaq: PODD), the global leader in patch pump technology, and the International Diabetes Federation (IDF) today announced that Insulet is an official partner of IDF's World Diabetes Day (WDD) campaign. World Diabetes Day, celebrated on November 14, will raise awareness of children and adolescents with diabetes, spotlighting both the impact of the disease and access to care. "Insulet's mission is to improve the lives of people with diabetes, so we felt it was imperative to join IDF to increase global awareness of this devastating disease, which affects millions of people worldwide," said Duane DeSisto, Insulet's president & chief executive officer. "Our easy-to-use OmniPod® Insulin Management System helps people with diabetes stay healthy while living life fully. OmniPod's innovative, tubing-free design provides all the benefits of pump therapy, which supplies the best control over diabetes, while eliminating the hassles of a traditional pump. Its virtually pain-free automated insertion has no needles in sight, which appeals to both children and adults. But primarily, OmniPod enables people with diabetes to simply live their lives normally." The campaign also emphasizes that, with the right treatment, children and adolescents can live full, healthy and productive lives. To ensure this, it's vital that parents know the early warning signs of diabetes and if their child shows these signs, to seek immediate medical attention. These signs include: -- Frequent urination -- Excessive thirst -- Increased hunger -- Rapid weight loss -- Tiredness -- Lack of interest and concentration -- Blurred vision -- Vomiting and stomach pain (often mistaken as the flu) "We are extremely pleased that Insulet is an official partner in World Diabetes Day and very much welcome their support and expertise in diabetes to bring attention to the disease," said World Diabetes Day Campaign Director Phil Riley. -
World Diabetes Day – November 14, 2020
World Diabetes Day – November 14, 2020 SATNOV 14 WHAT IS WORLD DIABETES DAY? World Diabetes Day is every year on November 14, first created in 1991 by the International Diabetes Foundation and the World Health Organization. Diabetes is a chronic disease where the pancreas doesn’t produce enough insulin if any at all. It also leads to serious health conditions and, in many ways, can be preventable. That’s why we take this day to spread awareness and education. HISTORY OF WORLD DIABETES DAY Diabetes is considered to have been around 1550 BC. The successful extraction and injection of insulin into humans was discovered in 1922. So, comparatively, our understanding of diabetes is quite new compared to its long, arduous march through history. The difference between type two and type one started around 1850, where medical professionals at the time believed that they knew enough of the difference between the two to warrant two categories. Since then, type II diabetes has ballooned to 90 percent of the those affected, with an estimated $425 million individuals affected worldwide. This alarming rise in such a preventable disease is one of the reasons the WHO and IDF wanted to create World Diabetes Day – to help spread awareness of how to prevent contracting the illness. Having to manage blood sugar levels on a daily basis is a time-consuming and costly endeavor, as the economic cost of diabetes globally is around $727 billion (USD) and in the US alone it costs almost a third of that, at $245 billion. The costliness and its prevention create even more reason for us to spread awareness of the disease, and also celebrate the birth of the man who helped bring insulin into the modern world as an effective treatment against it. -
BAOJ Diabetes Edson Da Silva, BAOJ Diabet 2017, 3: 2 3: 023
See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/317003906 World Diabetes Day Article · May 2017 CITATIONS READS 0 592 1 author: Edson Da Silva Federal University of Jequitinhonha and Mucuri Valleys 84 PUBLICATIONS 140 CITATIONS SEE PROFILE All content following this page was uploaded by Edson Da Silva on 03 September 2020. The user has requested enhancement of the downloaded file. BAOJ Diabetes Edson da Silva, BAOJ Diabet 2017, 3: 2 3: 023 Editorial World Diabetes Day *Edson da Silva Group of Studies and Research on Diabetes, Department of Basic Sciences, Federal University of Jequitinhonha and Mucuri Valleys, Brazil Editorial Article disadvantaged and vulnerable, and children/teenagers with or at risk for DM [4,5]. In 2014-2015, ‘Healthy Living and Diabetes’ was World Diabetes Day (WDD) is celebrated every year on November the theme of WDD. The theme for 2016 ‘Eyes on Diabetes’ focused 14. WDD was created in 1991 by IDF and the World Health on the importance of early screening for diabetes [2]. Organization (WHO) in response to the rapid rise of diabetes mellitus (DM) in the world [1]. Since 2006 the WDD became an The WDD campaign is represented by an IDF’s blue circle logo official United Nations Day with the passage of United Nation that was adopted in 2007 after the passage of the United Nation Resolution 61/225 [2]. Resolution on diabetes. The blue circle is the global symbol for diabetes awareness. It signifies the unity of the global diabetes November 14th was chosen as WDD because it is the birthday of community in response to the diabetes epidemic. -
Breakthrough: Elizabeth Hughes, the Discovery of Insulin, and the Making of a Medical Miracle Pdf
FREE BREAKTHROUGH: ELIZABETH HUGHES, THE DISCOVERY OF INSULIN, AND THE MAKING OF A MEDICAL MIRACLE PDF Thea Cooper,Arthur Ainsberg | 320 pages | 11 Nov 2011 | Griffin Publishing | 9780312611743 | English | California, United States Home - Arthur Ainsberg Goodreads helps you keep track of books you want to read. Want to Read saving…. Want to Read Currently Reading Read. Other editions. Enlarge cover. Error rating book. Refresh and try again. Open Preview See a Problem? Details if other :. Thanks for telling us about the Discovery of Insulin problem. Return to Book Page. Preview — Breakthrough by Thea Cooper. Arthur Ainsberg. It is and Elizabeth Hughes, the eleven-year-old daughter of America's most-distinguished jurist and politician, Charles Evans Hughes, has been diagnosed with juvenile diabetes. It is essentially a death sentence. The only accepted form of treatment - starvation - whittles her down to forty-five pounds skin and bones. Miles away, Canadian researchers Frederick Banting It is and Elizabeth Hughes, the eleven-year-old daughter of America's most-distinguished jurist and politician, Charles Evans Hughes, has been diagnosed with juvenile diabetes. Miles away, Canadian researchers Frederick Banting and Charles Best manage to identify and purify insulin from animal pancreases - a miracle soon marred by scientific jealousy, intense business competition and fistfights. In a race against time and a ravaging disease, Elizabeth becomes one of the first diabetics to receive insulin injections - all while its discoverers and a little known pharmaceutical company struggle to make it available to the rest of the world. Relive the heartwarming true story of the discovery of insulin as it's never been told before. -
“Our Objective Wasn't to Belittle People's Behavior”: The
FOY, MARJORIE ELVIN, Ph.D. “Our Objective Wasn’t to Belittle People’s Behavior”: The History of Gestational Diabetes, 1921-1991. (2013) Directed by Charles Bolton. 298 pp. The emergence of the disease concept of Gestational Diabetes Mellitus during the late twentieth century was a product of collaborative efforts between physicians, medical researchers, businesses, and government agencies. This work is fundamentally an institutional history of medicine, situated in three specific genres within the field: disease creation studies, the examination of U.S. public health, and healthcare consumer history. This work traces changes in scientific and medical views, as well as the broader shift in how diseases are defined as that process moved out of the medical clinic and research lab into the halls of policy makers and government agencies. Scientific discovery and understanding emanated from the work of medical researchers, but the post-World War II era in the United States saw government agencies and healthcare businesses gain important roles in defining diseases and in creating consumer identities for patients. This was especially visible with gestational diabetes because many of the women who made up the rising numbers of new cases in the second half of the twentieth century came from lower-income groups who accessed their healthcare through government-subsidized programs like Medicaid. Through a range of historical sources, I examine the development of this dynamic relationship between medical knowledge and practice; business ideologies and approaches in an expanding healthcare market; and government policy on healthcare. “OUR OBJECTIVE WASN’T TO BELITTLE PEOPLE’S BEHAVIOR” THE HISTORY OF GESTATIONAL DIABETES, 1921-1991 by Marjorie Elvin Foy A Dissertation Submitted to the Faculty of the Graduate School at The University of North Carolina at Greensboro in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy Greensboro 2013 Approved by Dr. -
A Systematic Review of the Prevalence and Treatment of Type 2 Diabetes in Nigeria
www.idosr.org Offu ©IDOSR PUBLICATIONS International Digital Organization for Scientific Research ISSN: 2579-0730 IDOSR JOURNAL OF BIOLOGY, CHEMISTRY AND PHARMACY 3(1) 124-146, 2019. A Systematic Review of the Prevalence and Treatment of Type 2 Diabetes in Nigeria. Ogochukwu Fidelia Offu Department of Clinical Pharmacy and Biopharmaceutics, Faculty of Pharmaceutical Sciences, Enugu State University of Science and Technology, Agbani, Enugu State, Nigeria. Email: [email protected] ABSTRACT Diabetes is on the increase in Nigeria and previous systematic reviews and meta- analysis have reported estimates of the prevalence of Type 2 Diabetes Mellitus in Nigeria. However, because of differences in population characteristics, these estimates will vary across and within geopolitical zones. Despite the increase in prevalence of Type 2 Diabetes Mellitus in the country, no other systematic review has been carried out to assess diabetes treatment pattern in Nigeria. Hence, the importance of this study, as it critically reviews the disease prevalence and treatment pattern across and within geopolitical zones in Nigeria.To systematically review all prevalence and treatment studies published from January, 1998 to September, 2018. The following databases were searched for articles: PubMed Central (PMC), African Journal On Line (AJOL), Science Direct, and Connecting Repositories (CORE). Google scholar was also searched. 159 articles were identified from the databases while 12 were identified from Google Scholar. Studies that were excluded are: Studies that dealt mainly the prevalence of Type 1 Diabetes Melitus/gestational diabetes (14); studies with self reported diagnosis (12); case reports and editorials (10); studies that were not representative of the general population (7); and studies without case definitions (8) were excluded from the pool of studies to obtain 38 studies that were utilized for the review. -
Nomination Form
International Memory of the World Register The Discovery of Insulin and its Worldwide Impact (Canada) 2012-12 1.0 Summary (max 200 words) The documentary heritage being nominated is the total archive pertaining to the discovery of insulin at the University of Toronto. This event was one of the most significant medical discoveries of the twentieth century and it is thoroughly documented in the archive, in a number of related fonds. The discovery of insulin archival collections contain original handwritten notes by the scientific team of Frederick Grant Banting (1891-1941), Charles Herbert Best (1899-1978), James Bertram Collip(1892-1965) and John James Rickard Macleod (1876-1935) concerning early experiments, and the successful formula for insulin, as well as patient charts, papers, reports, correspondence between doctors, researchers, patients’ response, the Eli Lilly company and the University of Toronto. Research and teaching in the Faculty of Medicine has always been strong at the University of Toronto, with a long and distinguished history and those familiar with this tradition are not surprised by the discovery of insulin here. While credit for the discovery must be officially given to Banting, Best, Collip and Macleod, their work was based on a solid foundation of research performed by a number of world-class researchers at the University of Toronto, as well as building on research being carried out by others around the world. While Dr. Banting had little experience in medical research at the time, Dr. Macleod recognized that the exact procedures which Dr. Banting suggested had never been tried before to his knowledge, and also felt that even negative results would be of value to diabetic research.